First Trust Advisors’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6M Buy
190,879
+86,229
+82% +$5.61M 0.01% 938
2026
Q1
$4.97M Buy
+104,650
New +$4.69M ﹤0.01% 1442
2025
Q4
Sell
-20,413
Closed -$574K 2715
2025
Q3
$574K Sell
20,413
-36,331
-64% -$1.1M ﹤0.01% 2284
2025
Q2
$2.09M Buy
56,744
+2,032
+4% +$70.2K ﹤0.01% 1798
2025
Q1
$2.15M Sell
54,712
-28,688
-34% -$1.29M ﹤0.01% 1752
2024
Q4
$3.88M Sell
83,400
-93,124
-53% -$4.21M ﹤0.01% 1499
2024
Q3
$7.98M Buy
176,524
+80,545
+84% +$3.83M 0.01% 1118
2024
Q2
$4.73M Sell
95,979
-30,817
-24% -$1.26M ﹤0.01% 1289
2024
Q1
$4.35M Buy
126,796
+29,890
+31% +$1.08M ﹤0.01% 1373
2023
Q4
$3.57M Buy
96,906
+36,018
+59% +$833K ﹤0.01% 1464
2023
Q3
$1.23M Buy
+60,888
New +$1.34M ﹤0.01% 1889
2022
Q1
Sell
-7,144
Closed -$553K 2590
2021
Q4
$553K Sell
7,144
-22,568
-76% -$2.32M ﹤0.01% 2267
2021
Q3
$3.18M Buy
29,712
+1,443
+5% +$165K ﹤0.01% 1575
2021
Q2
$3.77M Sell
28,269
-8,470
-23% -$985K ﹤0.01% 1523
2021
Q1
$4.55M Sell
36,739
-720
-2% -$109K 0.01% 1303
2020
Q4
$5.29M Buy
+37,459
New +$4.16M 0.01% 1074

Other funds holding TWST

First Trust Advisors's TWST Position: Q2 2026 in Review

First Trust Advisors increased its Twist Bioscience (TWST) stake by 82% in Q2 2026, buying an estimated $5.61M and bringing the position to 190,879 shares worth $19.6M. The position accounts for 0.01% of the portfolio, ranked #938.

First Trust Advisors first reported a position in TWST in Q4 2020 and has held it in 16 quarters since. 237 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • First Trust Advisors held 190,879 shares of Twist Bioscience worth $19.6M as of Q2 2026.
  • First Trust Advisors bought 86,229 Twist Bioscience shares in Q2 2026, an estimated $5.61M.
  • Twist Bioscience made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #938 holding.
  • First Trust Advisors first reported a position in Twist Bioscience in Q4 2020 and has held it in 16 quarters since.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.